Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZUNYSE:APTNYSE:MLSSNASDAQ:NTRB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUAnzu Special Acquisition Corp I$1.44-7.1%$1.76$5.21▼$11.72$21.51M0.03109,623 shs47,875 shsAPTAlpha Pro Tech$4.72-1.4%$4.49$4.06▼$6.44$51.31M0.3431,441 shs54,865 shsMLSSMilestone Scientific$0.90-0.8%$0.95$0.58▼$1.39$70.79M0.93127,861 shs61,407 shsNTRBNutriband$7.30-10.8%$5.71$3.72▼$11.78$81.42M1.1180,416 shs55,342 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUAnzu Special Acquisition Corp I+3.33%-0.64%+14.81%+18.32%-31.72%APTAlpha Pro Tech-1.44%+4.36%+7.88%-10.30%+1.70%MLSSMilestone Scientific-1.13%-6.13%-9.04%-10.82%+20.65%NTRBNutriband+6.10%+29.64%+27.61%+18.72%+37.94%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANZUAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/AAPTAlpha Pro TechN/AN/AN/AN/AN/AN/AN/AN/AMLSSMilestone Scientific2.8836 of 5 stars3.55.00.00.01.92.50.0NTRBNutriband2.3116 of 5 stars3.52.00.00.02.51.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUAnzu Special Acquisition Corp I 0.00N/AN/AN/AAPTAlpha Pro Tech 0.00N/AN/AN/AMLSSMilestone Scientific 3.00Buy$1.2538.58% UpsideNTRBNutriband 3.00Buy$13.0078.08% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUAnzu Special Acquisition Corp IN/AN/A$0.39 per share3.74($1.69) per shareN/AAPTAlpha Pro Tech$58.18M0.88$0.37 per share12.80$5.29 per share0.89MLSSMilestone Scientific$8.61M8.22N/AN/A$0.11 per share8.20NTRBNutriband$2.40M33.95N/AN/A$0.73 per share10.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUAnzu Special Acquisition Corp I$19.23MN/A0.00∞N/AN/A-17.33%1.37%N/AAPTAlpha Pro Tech$4.19M$0.3712.76∞N/A6.99%6.70%5.76%N/AMLSSMilestone Scientific-$6.93M-$0.07N/A∞N/A-52.01%-60.26%-40.23%N/ANTRBNutriband-$5.49M-$0.90N/AN/AN/A-338.51%-54.49%-48.52%N/ALatest ANZU, MLSS, NTRB, and APT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/30/2025Q1 2026NTRBNutriband-$0.13-$0.12+$0.01-$0.12$0.71 million$0.67 million4/28/2025Q4 2025NTRBNutriband-$0.12-$0.18-$0.06-$0.51$0.71 million$0.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANZUAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AAPTAlpha Pro TechN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/ANTRBNutribandN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANZUAnzu Special Acquisition Corp IN/A0.040.04APTAlpha Pro TechN/A19.0011.21MLSSMilestone ScientificN/A2.851.86NTRBNutriband0.014.964.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUAnzu Special Acquisition Corp I27.26%APTAlpha Pro Tech22.69%MLSSMilestone Scientific5.79%NTRBNutriband19.70%Insider OwnershipCompanyInsider OwnershipANZUAnzu Special Acquisition Corp I0.67%APTAlpha Pro Tech15.00%MLSSMilestone Scientific24.75%NTRBNutriband54.09%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUAnzu Special Acquisition Corp I314.94 million14.84 millionNot OptionableAPTAlpha Pro Tech12010.86 million9.46 millionOptionableMLSSMilestone Scientific3078.48 million58.61 millionOptionableNTRBNutriband1011.15 million5.10 millionNot OptionableANZU, MLSS, NTRB, and APT HeadlinesRecent News About These CompaniesResearch Analysts Set Expectations for Nutriband Q2 EarningsJune 5 at 6:10 AM | marketbeat.comNutriband (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl DevelopmentJune 4 at 9:35 AM | theglobeandmail.comNutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity ConferenceJune 3 at 9:53 AM | finance.yahoo.comNutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA FentanylJune 2 at 11:50 PM | finance.yahoo.comNutriband (NASDAQ:NTRB) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPSMay 31, 2025 | marketbeat.comNutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue EstimatesMay 30, 2025 | zacks.comIBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.May 27, 2025 | finance.yahoo.comNutriband (NTRB) Projected to Post Earnings on FridayMay 25, 2025 | marketbeat.comNutriband (NASDAQ: NTRB) Charts Path to CommercializationMay 24, 2025 | theglobeandmail.comNutriband (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal PatchMay 15, 2025 | theglobeandmail.comNutriband projects strong sales for abuse-deterrent patchesMay 1, 2025 | investing.comNutriband CEO Publishes Letter to ShareholdersApril 30, 2025 | globenewswire.comNutriband granted patent in Macao for its AVERA systemsApril 12, 2025 | markets.businessinsider.comNutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal TechnologyApril 11, 2025 | globenewswire.comNutriband (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand VisibilityApril 5, 2025 | theglobeandmail.comUPDATE – Nutriband Signs Associate Partnership with Charlotte FCApril 4, 2025 | globenewswire.comNutriband Signs Partnership Agreement with Charlotte FCApril 4, 2025 | globenewswire.comNutriband receives Certificate of Registration from USPTO for trademarkFebruary 21, 2025 | markets.businessinsider.comNutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.February 21, 2025 | globenewswire.comNutriband and Kindeva to Co-Develop Aversa Fentanyl Abuse-Deterrent PatchFebruary 15, 2025 | contractpharma.comNoble Financial Sticks to Its Buy Rating for Nutriband (NTRB)February 14, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeANZU, MLSS, NTRB, and APT Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUAnzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. Anzu Special Acquisition Corp I was incorporated in 2020 and is based in Tampa, Florida. Anzu Special Acquisition Corp I operates as a subsidiary of Anzu SPAC GP I LLC.Alpha Pro Tech NYSE:APT$4.64 -0.15 (-3.11%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, synthetic roof underlayment, and self-adhered roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.Milestone Scientific NYSE:MLSS$0.90 -0.01 (-0.84%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Nutriband NASDAQ:NTRB$7.30 -0.88 (-10.76%) Closing price 03:59 PM EasternExtended Trading$7.30 0.00 (0.00%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise Robinhood Stock Keeps Giving Investors Reasons To Buy Hims & Hers Stock: Buy the Dip or Wait It Out? Boeing: Analyst Upgrades & Order Boom Signal Clearer Skies CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast A New All-Time High Is Coming Soon for Credo Technology Group Guidewire Rockets Higher: A Move Above $300 Is Probable Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
